P. Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
P. Chen has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Shan-Yu Fung
State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, No. 22 Qixiangtai Road, Heping District, Tianjin 300070, China
6 shared publications - Hong Yang
Department of Pharmacology and Tianjin Key Laboratory of Inflammation Biology, The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, School of Basic Medical Sciences, Tianjin Medical University, No. 22 Qixiangtai Road, Heping District, Tianjin 300070, China
5 shared publications J. Long
Department of Chemical Engineering, University of Waterloo, 200 University Ave. W., Waterloo, Ontario, Canada N2L 3G1
3 shared publicationsC. Tzoganakis
Department of Chemical Engineering, University of Waterloo, 200 University Ave. W., Waterloo, Ontario, Canada, N2L 3G1
2 shared publicationsJ. Bechhoefer
Simon Fraser Physics, Burnaby, B.C., Canada, V5A 1S6
2 shared publications- Jean Duhamel
Institute for Polymer Research, Department of Chemistry, University of Waterloo, Waterloo, Ont., Canada N2L 3G1
2 shared publications
Latest Publications
- 13 April 2010
- Published by Springer Nature in Frontiers of Materials Science in China
- Vol. 4 (2) , 145-151
Constructing biomaterials using self-assembling peptide building blocks
- 13 April 2010
- Published by Springer Nature in Frontiers of Materials Science in China
- Vol. 4 (2) , 145-151
Constructing biomaterials using self-assembling peptide building blocks
- 29 December 2008
- Published by Wiley in Advanced Functional Materials
- Vol. 19 (1) , 74-83
Self‐Assembling Peptide as a Potential Carrier for Hydrophobic Anticancer Drug Ellipticine: Complexation, Release and In Vitro Delivery
The self‐assembling peptide EAK16‐II is capable of stabilizing hydrophobic compounds to form microcrystal suspensions in aqueous solution. Here, the ability of this peptide to stabilize the hydrophobic anticancer agent ellipticine is investigated. The formation of peptide‐ellipticine suspensions is monitored with time until equilibrium is reached. The equilibration time is found to be dependent on the peptide concentration. When the peptide concentration is close to its critical aggregation concentration, the equilibration time is minimal at 5 h. With different combinations of EAK16‐II and ellipticine concentrations, two molecular states (protonated or cyrstalline) of ellipticine could be stabilized. These different states of ellipticine significantly affect the release kinetics of ellipticine from the peptide‐ellipticine complex into the egg phosphatidylcholine vesicles, which are used to mimic cell membranes. The transfer rate of protonated ellipticine from the complex to the vesicles is much faster than that of crystalline ellipticine. This observation may also be related to the size of the resulting complexes as revealed from the scanning electron micrographs. In addition, the complexes with protonated ellipticine are found to have a better anticancer activity against two cancer cell lines, A549 and MCF‐7. This work forms the basis for studies of the peptide‐ellipticine suspensions in vitro and in vivo leading to future development of self‐assembling peptide‐based delivery of hydrophobic anticancer drugs.
- 29 December 2008
- Published by Wiley in Advanced Functional Materials
- Vol. 19 (1) , 74-83
Self‐Assembling Peptide as a Potential Carrier for Hydrophobic Anticancer Drug Ellipticine: Complexation, Release and In Vitro Delivery
The self‐assembling peptide EAK16‐II is capable of stabilizing hydrophobic compounds to form microcrystal suspensions in aqueous solution. Here, the ability of this peptide to stabilize the hydrophobic anticancer agent ellipticine is investigated. The formation of peptide‐ellipticine suspensions is monitored with time until equilibrium is reached. The equilibration time is found to be dependent on the peptide concentration. When the peptide concentration is close to its critical aggregation concentration, the equilibration time is minimal at 5 h. With different combinations of EAK16‐II and ellipticine concentrations, two molecular states (protonated or cyrstalline) of ellipticine could be stabilized. These different states of ellipticine significantly affect the release kinetics of ellipticine from the peptide‐ellipticine complex into the egg phosphatidylcholine vesicles, which are used to mimic cell membranes. The transfer rate of protonated ellipticine from the complex to the vesicles is much faster than that of crystalline ellipticine. This observation may also be related to the size of the resulting complexes as revealed from the scanning electron micrographs. In addition, the complexes with protonated ellipticine are found to have a better anticancer activity against two cancer cell lines, A549 and MCF‐7. This work forms the basis for studies of the peptide‐ellipticine suspensions in vitro and in vivo leading to future development of self‐assembling peptide‐based delivery of hydrophobic anticancer drugs.
- Open Access
- 1 July 2008
- Published by Wiley in Biotechnology Progress
- Vol. 24 (4) , 964-971
Ionic‐complementary peptide‐modified highly ordered pyrolytic graphite electrode for biosensor application
Ionic‐complementary peptides are promising new biomaterials with potential applications in bionanotechnology. In the present investigation, a typical ionic‐complementary peptide, EFK16‐II, was used to modify a highly ordered pyrolytic graphite (HOPG) electrode. Upon modification, peptide nanofibers, parallel or oriented 60° or 120° to each other, were formed on the surface of HOPG electrode. Surface wettability of the electrode was improved as indicated by a significant decrease in the water contact angle. The electrochemical response of the EFK16‐II nanofiber‐modified HOPG electrode for the ferricyanide/ferrocyanide redox couple was characterized. Cyclic voltammograms indicated that the presence of peptide nanofibers on the HOPG electrode did not block electron transfer at slow scan rates (∼2 mV/s), but did so at high scan rates (∼ 100 mV/s). A model enzyme glucose oxidase (GOx) was covalently immobilized onto this nanofiber‐modified electrode, and its potential as an enzyme‐based biosensor for glucose was examined. At an applied potential of +0.45 V (vs. Ag/AgCl), the current increased linearly with glucose concentration up to 7.5 mM and a relative high sensitivity was obtained at 11.3 ± 1.0 nA/(mM mm2). The immobilized GOx showed high affinity for glucose, with a Michaelis–Menten constant Km of 6.8 ± 0.9 mM. It also exhibited relatively good storage and operational stabilities, and reflected in only a small decrease (13%) in the current response after 1 month storage and negligible changes upon 50 cyclic voltammetric scans. The results presented here demonstrate an excellent potential of the use of ionic‐complementary peptides to modify electrode surfaces for biomolecular sensing and diagnostics.
- 1 July 2008
- Published by Wiley in Biotechnology Progress
- Vol. 24 (4) , 964-971
Open AccessIonic‐complementary peptide‐modified highly ordered pyrolytic graphite electrode for biosensor application
Ionic‐complementary peptides are promising new biomaterials with potential applications in bionanotechnology. In the present investigation, a typical ionic‐complementary peptide, EFK16‐II, was used to modify a highly ordered pyrolytic graphite (HOPG) electrode. Upon modification, peptide nanofibers, parallel or oriented 60° or 120° to each other, were formed on the surface of HOPG electrode. Surface wettability of the electrode was improved as indicated by a significant decrease in the water contact angle. The electrochemical response of the EFK16‐II nanofiber‐modified HOPG electrode for the ferricyanide/ferrocyanide redox couple was characterized. Cyclic voltammograms indicated that the presence of peptide nanofibers on the HOPG electrode did not block electron transfer at slow scan rates (∼2 mV/s), but did so at high scan rates (∼ 100 mV/s). A model enzyme glucose oxidase (GOx) was covalently immobilized onto this nanofiber‐modified electrode, and its potential as an enzyme‐based biosensor for glucose was examined. At an applied potential of +0.45 V (vs. Ag/AgCl), the current increased linearly with glucose concentration up to 7.5 mM and a relative high sensitivity was obtained at 11.3 ± 1.0 nA/(mM mm2). The immobilized GOx showed high affinity for glucose, with a Michaelis–Menten constant Km of 6.8 ± 0.9 mM. It also exhibited relatively good storage and operational stabilities, and reflected in only a small decrease (13%) in the current response after 1 month storage and negligible changes upon 50 cyclic voltammetric scans. The results presented here demonstrate an excellent potential of the use of ionic‐complementary peptides to modify electrode surfaces for biomolecular sensing and diagnostics.
- Open Access
- 9 April 2008
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (4) , e1956
Sequence Effect of Self-Assembling Peptides on the Complexation and In Vitro Delivery of the Hydrophobic Anticancer Drug Ellipticine
A special class of self-assembling peptides has been found to be capable of stabilizing the hydrophobic anticancer agent ellipticine in aqueous solution. Here we study the effect of peptide sequence on the complex formation and its anticancer activity in vitro. Three peptides, EAK16-II, EAK16-IV and EFK16-II, were selected to have either a different charge distribution (EAK16-II vs. EAK16-IV) or a varying hydrophobicity (EAK16-II vs. EFK16-II). Results on their complexation with ellipticine revealed that EAK16-II and EAK16-IV were able to stabilize protonated ellipticine or ellipticine microcrystals depending on the peptide concentration; EFK16-II could stabilize neutral ellipticine molecules and ellipticine microcrystals. These different molecular states of ellipticine were expected to affect ellipticine delivery. The anticancer activity of these complexes was tested against two cancer cell lines: A549 and MCF-7, and related to the cell viability. The viability results showed that the complexes with protonated ellipticine were effective in eradicating both cancer cells (viability in vitro; however, the increase in hydrophobicity of the peptides significantly altered the state of stabilized ellipticine and increased the stability of the complexes. This work provides essential information for peptide sequence design in the development of self-assembling peptide-based delivery of hydrophobic anticancer drugs.
- 9 April 2008
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (4) , e1956
Open AccessSequence Effect of Self-Assembling Peptides on the Complexation and In Vitro Delivery of the Hydrophobic Anticancer Drug Ellipticine
A special class of self-assembling peptides has been found to be capable of stabilizing the hydrophobic anticancer agent ellipticine in aqueous solution. Here we study the effect of peptide sequence on the complex formation and its anticancer activity in vitro. Three peptides, EAK16-II, EAK16-IV and EFK16-II, were selected to have either a different charge distribution (EAK16-II vs. EAK16-IV) or a varying hydrophobicity (EAK16-II vs. EFK16-II). Results on their complexation with ellipticine revealed that EAK16-II and EAK16-IV were able to stabilize protonated ellipticine or ellipticine microcrystals depending on the peptide concentration; EFK16-II could stabilize neutral ellipticine molecules and ellipticine microcrystals. These different molecular states of ellipticine were expected to affect ellipticine delivery. The anticancer activity of these complexes was tested against two cancer cell lines: A549 and MCF-7, and related to the cell viability. The viability results showed that the complexes with protonated ellipticine were effective in eradicating both cancer cells (viability in vitro; however, the increase in hydrophobicity of the peptides significantly altered the state of stabilized ellipticine and increased the stability of the complexes. This work provides essential information for peptide sequence design in the development of self-assembling peptide-based delivery of hydrophobic anticancer drugs.
- Open Access
- 19 December 2007
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 2 (12) , e1325
Modification of Hydrophilic and Hydrophobic Surfaces Using an Ionic-Complementary Peptide
Ionic-complementary peptides are novel nano-biomaterials with a variety of biomedical applications including potential biosurface engineering. This study presents evidence that a model ionic-complementary peptide EAK16-II is capable of assembling/coating on hydrophilic mica as well as hydrophobic highly ordered pyrolytic graphite (HOPG) surfaces with different nano-patterns. EAK16-II forms randomly oriented nanofibers or nanofiber networks on mica, while ordered nanofibers parallel or oriented 60° or 120° to each other on HOPG, reflecting the crystallographic symmetry of graphite (0001). The density of coated nanofibers on both surfaces can be controlled by adjusting the peptide concentration and the contact time of the peptide solution with the surface. The coated EAK16-II nanofibers alter the wettability of the two surfaces differently: the water contact angle of bare mica surface is measured to be <10°, while it increases to 20.3±2.9° upon 2 h modification of the surface using a 29 µM EAK16-II solution. In contrast, the water contact angle decreases significantly from 71.2±11.1° to 39.4±4.3° after the HOPG surface is coated with a 29 µM peptide solution for 2 h. The stability of the EAK16-II nanofibers on both surfaces is further evaluated by immersing the surface into acidic and basic solutions and analyzing the changes in the nanofiber surface coverage. The EAK16-II nanofibers on mica remain stable in acidic solution but not in alkaline solution, while they are stable on the HOPG surface regardless of the solution pH. This work demonstrates the possibility of using self-assembling peptides for surface modification applications.
- 19 December 2007
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 2 (12) , e1325
Open AccessModification of Hydrophilic and Hydrophobic Surfaces Using an Ionic-Complementary Peptide
Ionic-complementary peptides are novel nano-biomaterials with a variety of biomedical applications including potential biosurface engineering. This study presents evidence that a model ionic-complementary peptide EAK16-II is capable of assembling/coating on hydrophilic mica as well as hydrophobic highly ordered pyrolytic graphite (HOPG) surfaces with different nano-patterns. EAK16-II forms randomly oriented nanofibers or nanofiber networks on mica, while ordered nanofibers parallel or oriented 60° or 120° to each other on HOPG, reflecting the crystallographic symmetry of graphite (0001). The density of coated nanofibers on both surfaces can be controlled by adjusting the peptide concentration and the contact time of the peptide solution with the surface. The coated EAK16-II nanofibers alter the wettability of the two surfaces differently: the water contact angle of bare mica surface is measured to be <10°, while it increases to 20.3±2.9° upon 2 h modification of the surface using a 29 µM EAK16-II solution. In contrast, the water contact angle decreases significantly from 71.2±11.1° to 39.4±4.3° after the HOPG surface is coated with a 29 µM peptide solution for 2 h. The stability of the EAK16-II nanofibers on both surfaces is further evaluated by immersing the surface into acidic and basic solutions and analyzing the changes in the nanofiber surface coverage. The EAK16-II nanofibers on mica remain stable in acidic solution but not in alkaline solution, while they are stable on the HOPG surface regardless of the solution pH. This work demonstrates the possibility of using self-assembling peptides for surface modification applications.
- 1 October 2007
- Published by Elsevier in Biophysical Journal
- Vol. 93 (7) , 2477-2490
Interaction of a Self-Assembling Peptide with Oligonucleotides: Complexation and Aggregation
- 1 October 2007
- Published by Elsevier in Biophysical Journal
- Vol. 93 (7) , 2477-2490
Interaction of a Self-Assembling Peptide with Oligonucleotides: Complexation and Aggregation
- 1 April 2007
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 55 (2) , 200-211
Formation of colloidal suspension of hydrophobic compounds with an amphiphilic self-assembling peptide
- 1 April 2007
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 55 (2) , 200-211
Formation of colloidal suspension of hydrophobic compounds with an amphiphilic self-assembling peptide
- 13 November 2006
- Published by Elsevier in Advances in Colloid and Interface Science
- Vol. 127 (2) , 55-66
On the role of energy barriers in determining contact angle hysteresis
- 13 November 2006
- Published by Elsevier in Advances in Colloid and Interface Science
- Vol. 127 (2) , 55-66
On the role of energy barriers in determining contact angle hysteresis
- 17 March 2005
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 286 (1) , 14-27
Modeling of adsorption dynamics at air–liquid interfaces using statistical rate theory (SRT)
- 17 March 2005
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 286 (1) , 14-27
Modeling of adsorption dynamics at air–liquid interfaces using statistical rate theory (SRT)
- 1 January 2005
- Published by Elsevier
Contributor contact details